BetterLife Pharma Settles Legal Claim with Dr. Steven Sangha
BetterLife Pharma Inc. has entered into a settlement agreement with director Dr. Steven Sangha to resolve a civil claim regarding a $2 million convertible debenture.
Stocks · News reference
Better Home & Finance Reports Preliminary Q3 Loan Volume Of $1.39B, Up 15%; Says ~$13.2M In Annualized Cost Cuts Implemented, $51M More Targeted
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Better Home & Finance Adds Josh Burruss and The Home Team to Retail Platform
Better Home & Finance Holding Company announced that Josh Burruss and The Home Team have joined its NEO Home Loans branch, bringing $82.5 million in 2025 funded volume.
BetterLife Pharma Appoints Henry Chow to Board of Directors
BetterLife Pharma Inc. has appointed Henry Chow, CPA, CA, to its Board of Directors, while Ralph Anthony (Tony) Pullen has resigned from the board to serve as an advisor.
Better Home & Finance Releases Week 4 Operational Scorecard
Better Home & Finance Holding Company published its fourth weekly 'Better 2.0' scorecard, detailing the launch of an AI-powered HELOC, new strategic partnerships, and continued corporate cost-reduction initiatives.
Better Home & Finance Releases Week 3 of Turnaround Scorecard
Better Home & Finance Holding Company reported additional cost-saving measures in its third weekly 'Better 2.0' scorecard, totaling $6.6 million in annualized savings for the week.
BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm
BetterLife Pharma Inc. has retained LifeSci Advisors to manage its investor relations and corporate communications as it progresses its lead drug candidate, BETR-001.